LNA Santé SA
LNA Santé SA (LNA.PA) Financial Performance & Income Statement Overview
Analyze LNA Santé SA (LNA.PA) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
LNA Santé SA (LNA.PA) Income Statement & Financial Overview
Analyze LNA Santé SA’s LNA.PA earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $416.98M | $389.62M | $372.41M | $363.67M |
| Cost of Revenue | $328.11M | $260.01M | $253.68M | $322.29M |
| Gross Profit | $88.88M | $129.61M | $118.73M | $41.38M |
| Gross Profit Ratio | $0.21 | $0.33 | $0.32 | $0.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $778000.00 | $45.68M | $34.60M | $2.75M |
| Operating Expenses | $4.91M | $96.51M | $85.72M | $17.88M |
| Total Costs & Expenses | -$333.01M | $356.52M | $339.40M | $340.17M |
| Interest Income | $0.00 | $123000.00 | $0.00 | $83000.00 |
| Interest Expense | $0.00 | $14.43M | $0.00 | $12.83M |
| Depreciation & Amortization | $0.00 | $11.15M | $11.17M | $39.78M |
| EBITDA | $65.03M | $44.31M | $42.63M | $71.40M |
| EBITDA Ratio | $0.16 | $0.11 | $0.11 | $0.17 |
| Operating Income | $83.97M | $33.10M | $31.46M | $23.50M |
| Operating Income Ratio | $0.20 | $0.08 | $0.08 | $0.06 |
| Other Income/Expenses (Net) | -$69.37M | -$14.25M | -$12.90M | -$4.71M |
| Income Before Tax | $14.60M | $18.85M | $18.61M | $18.79M |
| Income Before Tax Ratio | $0.04 | $0.05 | $0.05 | $0.05 |
| Income Tax Expense | $5.007M | $6.02M | $6.58M | $6.44M |
| Net Income | $9.45M | $12.37M | $11.47M | $11.93M |
| Net Income Ratio | $0.02 | $0.03 | $0.03 | $0.03 |
| EPS | $0.83 | $1.21 | $1.13 | $1.16 |
| Diluted EPS | $0.83 | $1.21 | $1.13 | $1.16 |
| Weighted Avg Shares Outstanding | $11.42M | $10.22M | $10.19M | $10.25M |
| Weighted Avg Shares Outstanding (Diluted) | $11.42M | $10.22M | $10.19M | $10.25M |
Over the last four quarters, LNA Santé SA's revenue moved from $363.67M in Q2 2023 to $416.98M in Q4 2024. Operating income in Q4 2024 was $83.97M, with a strong operating margin of 20%. Despite fluctuations in R&D and SG&A expenses, EBITDA for LNA Santé SA remained robust at $65.03M, reflecting operational efficiency. Net income dropped to $9.45M, with an EPS of $0.83. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan